Leslie, Daniel B.

Roux-en-Y Gastric Bypass vs Intensive Medical Management for the Control of Type 2 Diabetes, Hypertension, and Hyperlipidemia: The Diabetes Surgery Study Randomized Clinical Trial

Ikramuddin, S., Korner, J., Lee, W.-J., Connett, J. E., Inabnet, W. B., Billington, C. J., Thomas, A. J., Leslie, D. B., Chong, K., Jeffery, R. W., et al. (2013) · JAMA

Bariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 735

Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A 1c , LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study

Ikramuddin, S., Korner, J., Lee, W.-J., Thomas, A. J., Connett, J. E., Bantle, J. P., Leslie, D. B., Wang, Q., Inabnet, W. B., Jeffery, R. W., et al. (2018) · JAMA

Bariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 291

Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial

Ikramuddin, S., Blackstone, R. P., Brancatisano, A., Toouli, J., Shah, S. N., Wolfe, B. M., Fujioka, K., Maher, J. W., Swain, J., Que, F. G., et al. (2014) · JAMA

Bariatric Surgery and OutcomesVagus Nerve Stimulation Research

Cited by 214

Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial

Ikramuddin, S., Billington, C. J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Jeffery, R. W., Chong, K., et al. (2015) · The Lancet Diabetes & Endocrinology

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 207

Randomized sham‐controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial

Sullivan, S., Swain, J. M., Woodman, G., Antonetti, M., De La Cruz‐Muñoz, N., Jonnalagadda, S. S., Ujiki, M., Ikramuddin, S., Ponce, J., Ryou, M., et al. (2017) · Obesity

Bariatric Surgery and OutcomesPharmacology and Obesity Treatment

Cited by 179

Durability of Addition of Roux-en-Y Gastric Bypass to Lifestyle Intervention and Medical Management in Achieving Primary Treatment Goals for Uncontrolled Type 2 Diabetes in Mild to Moderate Obesity: A Randomized Control Trial

Ikramuddin, S., Korner, J., Lee, W.-J., Bantle, J. P., Thomas, A. J., Connett, J. E., Leslie, D. B., Inabnet, W. B., Wang, Q., Jeffery, R. W., et al. (2016) · Diabetes Care

Bariatric Surgery and OutcomesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 99

Roux-en-Y Gastric Bypass Acutely Decreases Protein Carbonylation and Increases Expression of Mitochondrial Biogenesis Genes in Subcutaneous Adipose Tissue

Jahansouz, C., Serrot, F. J., Frohnert, B. I., Foncea, R. E., Dorman, R. B., Slusarek, B., Leslie, D. B., Bernlohr, D. A., & Ikramuddin, S. (2015) · Obesity Surgery

Bariatric Surgery and OutcomesAdipose Tissue and Metabolism

Cited by 32